SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-20-000184
Filing Date
2020-06-22
Accepted
2020-06-22 16:08:46
Documents
91
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnbt043020form10q.htm 10-Q 1372786
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11913
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11883
4 EXHIBIT 32 ex32.htm EX-32 3831
11 GRAPHIC image_001.jpg GRAPHIC 5829
12 EXHIBIT 10.37 ex10_37.htm EX-10.37 17389
13 EXHIBIT 10.38 ex10_38.htm EX-10.38 42878
14 EXHIBIT 10.39 ex10_39.htm EX-10.39 43473
15 GRAPHIC image_002.gif GRAPHIC 3750
  Complete submission text file 0001607062-20-000184.txt   5771983

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20200430.xml EX-101.INS 863764
6 XBRL SCHEMA FILE gnbt-20200430.xsd EX-101.SCH 73190
7 XBRL CALCULATION FILE gnbt-20200430_cal.xml EX-101.CAL 72902
8 XBRL DEFINITION FILE gnbt-20200430_def.xml EX-101.DEF 244087
9 XBRL LABEL FILE gnbt-20200430_lab.xml EX-101.LAB 401269
10 XBRL PRESENTATION FILE gnbt-20200430_pre.xml EX-101.PRE 372571
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 20978895
SIC: 2834 Pharmaceutical Preparations